Can you provide the expected long term growth rate for PETROS PHARMACEUTICALS INC stock?
The expected long term growth rate for PETROS PHARMACEUTICALS INC (PTPI) is 26.71%.
PETROS PHARMACEUTICALS INC (PTPI) Forecast, Price Target & Analyst Ratings
NASDAQ:PTPI • US71678J2096
Current stock price
0.0664 USD
-0.06 (-46.45%)
At close:
0.0356 USD
-0.03 (-46.39%)
After Hours:
Analyst forecast overview
View the latest analyst price targets, stock forecast, EPS estimates, revenue projections, revisions, full estimates, rating distribution and upgrades/downgrades for PETROS PHARMACEUTICALS INC (PTPI).
Forecast Snapshot
Price Target Details & History
Consensus Price Target and Range
Mean target
N/A
Upside
N/A
From current price of $0.07 to mean target of N/A, Based on 7 analyst forecasts
Low
N/A
Median
N/A
High
N/A
Price Target Revisions
1 Month
0.00%
3 Months
0.00%
Price Target Summary
Analyst Ratings & History
Current Analyst Ratings
Analyst Ratings History
Analyst Ratings Consensus
ChartMill Buy Consensus
82.86%
PTPI was analyzed by 7 analysts. The buy percentage consensus is at 83. So analysts seem to be very confident about PTPI.
In the previous month the buy percentage consensus was at a similar level.
PTPI was analyzed by 7 analysts. More opinions would make the average more meaningful.
Recent Upgrades & Downgrades
| Date | Firm | Action | From → To |
|---|---|---|---|
| 2023-12-08 | Maxim Group | Initiate | Buy |
Next Earnings Forecast Details
Next Earnings Details
- Release Date
- N/A
Next Earnings Revisions
Revenue (1 Month)
N/A
Revenue (3 Months)
N/A
EPS (1 Month)
N/A
EPS (3 Months)
N/A
Next Earnings Summary
Full Analyst Estimates 2025 - 2030
Yearly Earnings Per Share (EPS), Revenue, EBIT, EBITDA and Operating Margin Analyst Estimates
| 2022 | 2023 | 2024 | 2025 | 2026 | 2027 | 2028 | 2029 | 2030 | ||
|---|---|---|---|---|---|---|---|---|---|---|
| Revenue YoY % growth | 5.99M -23.30% | 5.822M -2.80% | 5.112M -12.20% | 5.585M 9.25% | 5.562M -0.41% | 11.277M 102.75% | 22.903M 103.09% | 33.147M 44.73% | 44.567M 34.45% | |
| EBITDA YoY % growth | -10.25M 8.24% | -10.334M -0.82% | -7.465M 27.77% | N/A | N/A | N/A | N/A | N/A | N/A | |
| EBIT YoY % growth | -15.85M 12.19% | -13.617M 14.09% | -10.296M 24.39% | -12.264M -19.12% | -12.471M -1.68% | -8.428M 32.41% | -6.12K 99.93% | 8.712M 142,452.94% | 17.452M 100.32% | |
| Operating Margin | -264.61% | -233.88% | -201.41% | -219.60% | -224.21% | -74.74% | -0.03% | 26.28% | 39.16% | |
| EPS YoY % growth | N/A | N/A | N/A 98.35% | -1.11 48.83% | -1.12 -0.92% | -0.71 36.36% | 0.00 100.00% | 0.73 | 1.47 100.00% |
All data in USD
Quarterly Earnings Per Share (EPS), Revenue, EBIT and EBITDA Analyst Estimates
| EPS Q2Q % growth |
|---|
| Revenue Q2Q % growth |
| EBITDA Q2Q % growth |
| EBIT Q2Q % growth |
All data in USD
Yearly Earnings Per Share (EPS) and Revenue Trends vs Historical Data
Long Term Forward Growth Forecast Summary
Long Term EPS Growth (CAGR)
EPS Next 3 Year
18.67%
EPS Next 5 Year
18.51%
Long Term Revenue Growth (CAGR)
Revenue Next 3 Year
26.71%
Revenue Next 5 Year
43.00%
Long Term EBIT Growth (CAGR)
EBIT Next 3 Year
N/A
EBIT Next 5 Year
N/A